Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Jana Moravcová.
Blood Reviews | 2007
Jana Zelená; Hana Konečná; Zbyněk Zdráhal; Ondrej Šedo; Jana Moravcová; Marcela Rycová; Drahomíra Kyjovská; Božena Hanáková; Roman Hájek
Multiple myeloma (MM) is a B-cell malignancy characterized by proliferation and accumulation of B lymphocytes and plasma cells, secreting monoclonal immunoglobulins, in the bone marrow and, less frequently, at extramedullary sites. Proteome analysis of clinical samples aims at characterizing disease-specific changes in the protein expression profile of an affected cell. Such changes could serve as potential diagnostic markers. Two-dimensional polyacrylamide gel electrophoresis (2-DE) is widely used in comparative studies of protein expression levels. The potential of this method is strongly dependent on good sample preparation, in order to obtain proteomic maps with good reproducibility and resolution. Aims. The aim of this study was to optimize two-dimensional electrophoresis (2-DE) conditions for separation of human myeloma proteins. Methods. We have compared two different solubilization buffers, we also evaluated protein precipitation with ethanol (EtOH) and optimized 2-DE conditions for human myeloma proteins. Myeloma cell line ARH-77 was used to in the pilot study. Proteins from myeloma cell line ARH-77 were separated by 2-DE using a 17 cm pH 3-10 nonlinear immobilized pH gradient strips in the first dimension. Separation in the second-dimension was carried out on the Protean II Cell (Bio-Rad) using a 12% SDS-polyacrylamide gel. Separated proteins were stained with ProteoSilver Plus (Sigma). Spot detection, quantification, and alignment were performed with the PDQuest software (version 7.3.0., Bio-Rad). Results. Two concentrations of the detergent CHAPS (3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate) in the solubilization buffer were tested, 2% and 4%. Higher concentration of CHAPS showed a greater ability to solubilize proteins. The most efficient solubilization was obtained with lysis buffer containing 7 M urea, 2 M thiourea, 4% CHAPS, 60 mM DTT (dithiothreitol), 0.8% carrier ampholytes and 0.003% BPB (bromphenol blue). About 1448 spots were visualized in the gel using this lysis buffer. Many proteins (206 spots) were lost after the EtOH precipitation, though. Conclusions. Initial extraction and solubilization are key factors of proteomic analysis. The successful solubilization and 2-DE separation of proteins will be valuable tool for further study of the mechanisms of therapy resistance in purified plasma cells of patients with MM and further study of the biomarkers for prediction of progression of MGUS to overt myeloma.
Klinická onkologie : casopis Ceské a Slovenské onkologické spolecnosti | 2009
Darina Očadlíková; Lenka Zahradová; Lucie Kovarova; Jana Smejkalová; Luděk Pour; Petra Vidláková; Drahomíra Kyjovská; Jana Moravcová; Marcela Rycová; H. Novotná; Jelínková I; Miroslav Penka; Jaroslav Michálek; Hájek R
Klinická onkologie Supplement 2008 | 2008
Ivana Burešová; Jana Čumová; Lucie Kovářová; Drahomíra Kyjovská; Petra Vidláková; Renata Suská; Tomáš Perutka; Jana Moravcová; Marcela Rycová; Miroslav Penka; Roman Hájek
Klinická onkologie Supplement 2008 | 2008
Jana Čumová; Ivana Burešová; Lucie Kovářová; Drahomíra Kyjovská; Petra Vidláková; Renata Suská; Tomáš Perutka; Jana Moravcová; Marcela Rycová; Miroslav Penka; Roman Hájek
Archive | 2010
Ivana Burešová; Drahomíra Kyjovská; Jana Štossová; Lucie Kovářová; Jana Moravcová; Marcela Štouračová; Jana Čumová; Roman Hájek
Archive | 2009
Ivana Burešová; Karthick Raja Muthu Raja; Lucie Kovářová; Renata Suská; Tomáš Perutka; Drahomíra Kyjovská; Jana Moravcová; Renata Kupská; Miroslav Penka; Roman Hájek
Archive | 2009
Lenka Zahradová; Klára Macková; Darina Očadlíková; Lucie Kovářová; Drahomíra Kyjovská; Petra Vidláková; Jana Moravcová; Fedor Kryukov; Roman Hájek; Jaroslav Michálek
Archive | 2009
Ivana Burešová; Karthick Raja Muthu Raja; Drahomíra Kyjovská; Jana Moravcová; Marcela Rycová; Božena Hanáková; Roman Hájek
Klinická onkologie | 2009
Darina Očadlíková; Lenka Zahradová; Lucie Kovářová; Jana Smejkalová; Luděk Pour; Petra Vidláková; Drahomíra Kyjovská; Jana Moravcová; Marcela Rycová; H. Novotná; I. Jelínková; Miroslav Penka; Jaroslav Michálek; Roman Hájek
Archive | 2008
Drahomíra Kyjovská; Jana Čumová; Luděk Pour; Petra Vidláková; Jana Moravcová; Marcela Rycová; Miroslav Penka; Roman Hájek